cryptococcu
emerg
global
health
threat
annual
respons
infect
one
third
aid
patient
death
ongo
outbreak
cryptococcosi
western
unit
state
canada
cryptococcosi
diseas
result
inhal
infecti
propagul
environ
current
frequent
use
anim
infect
model
initi
infect
via
liquid
suspens
intranas
instil
intraven
inject
model
replic
typic
dri
natur
aerosol
exposur
may
hinder
abil
deciph
initi
event
lead
clearanc
establish
infect
establish
standard
aerosol
model
murin
infect
human
fungal
pathogen
cryptococcu
aerosol
cell
gener
util
collison
nebul
wholebodi
madison
chamber
differ
humid
condit
aerosol
insid
chamber
sampl
use
biosampl
determin
viabl
aerosol
concentr
spray
factor
ratio
viabl
aerosol
concentr
total
inoculum
concentr
effect
deliv
yeast
yeastspor
mixtur
lung
mice
observ
establish
diseas
observ
growth
condit
prior
exposur
humid
within
madison
chamber
exposur
alter
cryptococcu
surviv
dose
retain
mice
citat
springer
dj
saini
byrn
ej
heitman
j
frothingham
r
develop
aerosol
model
cryptococcu
reveal
humid
import
factor
affect
viabil
cryptococcu
aerosol
plo
one
cryptococcosi
opportunist
fungal
infect
caus
cryptococcu
predomin
caus
morbid
mortal
immunocompromis
hivposit
host
cryptococcu
respons
approxim
onethird
aid
relat
death
preval
caus
hivrel
mortal
subsaharan
africa
tuberculosi
develop
countri
infect
result
cryptococcu
second
tuberculosi
frequent
cooccur
togeth
develop
new
antifung
highli
activ
antivir
treatment
haart
combin
therapi
regimen
increas
longterm
surviv
rate
infect
remain
difficult
treat
frequent
reoccur
cryptococcu
increasingli
associ
rise
number
infect
seemingli
healthi
human
anim
worldwid
three
close
relat
speciesvarieti
cryptococcu
neoforman
var
neoforman
c
neoforman
var
grubii
c
gattii
predominantli
respons
human
anim
infect
c
neoforman
var
grubii
preval
clinic
isol
worldwid
howev
c
neoforman
var
neoforman
preval
region
europ
c
gattii
preval
caus
cryptococcosi
immunocompet
host
howev
region
world
c
gattii
increasingli
identifi
caus
infect
immunocompromis
host
cryptococc
infect
result
inhal
infecti
particl
yeast
cell
spore
environ
develop
overt
diseas
result
acut
latent
chronic
infect
natur
c
neoforman
var
neoforman
frequent
isol
avian
habitat
guano
c
gattii
frequent
isol
tree
soil
c
neoforman
var
grubii
preval
worldwid
frequent
associ
avian
habitat
also
tree
soil
frequent
isol
cryptococcu
plant
mate
associ
plant
tree
soil
avian
guano
suggest
import
environment
nich
develop
infecti
propagul
ie
spore
mainten
infecti
reservoir
cryptococcu
promin
environment
organ
human
frequent
expos
airborn
infecti
propagul
inhal
environment
growth
condit
airborn
infecti
rout
influenc
risk
develop
diseas
present
unknown
laboratori
condit
yeast
cell
spore
effect
initi
diseas
differ
size
mass
due
small
size
spore
presum
spore
effect
aerosol
natur
thu
effici
enter
bronchial
tube
alveolar
space
within
lung
addit
spore
implic
promot
infect
contrast
yeast
cell
requir
opson
phagocytosi
macrophag
macrophag
play
pivot
role
earli
host
defens
cryptococcu
ongo
outbreak
c
gattii
unit
state
canada
renew
interest
better
understand
acquisit
develop
cryptococcosi
infect
result
inhal
infecti
yeast
cell
spore
predominantli
model
util
tailvein
inject
intranas
instil
murin
model
host
although
methodolog
caus
morbid
mortal
neither
truli
mimic
inhal
infecti
particl
methodolog
requir
yeast
andor
spore
administ
within
suspens
inocul
rout
high
dosag
cell
util
initi
fluid
solut
could
alter
initi
immun
respons
downstream
sequela
appropri
control
cryptococc
infect
depend
intact
immun
system
includ
macrophag
neutrophil
cell
appropri
product
activ
cytokin
mount
evid
suggest
signific
differ
risk
infect
develop
diseas
progress
host
surviv
differ
cryptococcu
speci
current
murin
model
frequent
use
fall
short
replic
actual
aerosol
rout
infect
may
hinder
abil
deciph
initi
event
lead
clearanc
establish
latent
progress
infect
therefor
model
may
accur
reflect
virul
properti
spore
versu
yeast
mate
type
versu
strain
differ
molecular
type
speci
aerosol
infect
model
cryptococcu
fungi
rare
util
histor
applic
approach
includ
crude
exposur
soil
inocul
cryptococcu
util
jet
nebul
infect
henderson
chamber
inform
extract
soil
seed
infect
limit
infect
rate
develop
diseas
variabl
mice
expos
multipl
day
dosag
cell
mice
expos
versu
dose
initi
retain
lung
delin
infect
initi
henderson
chamber
result
consist
infect
rate
develop
diseas
comparison
crude
soil
exposur
mice
expos
aerosol
cryptococcu
basidiospor
via
jet
nebul
succumb
infect
variabl
infect
rate
diseas
develop
like
due
differ
inoculum
use
method
aerosol
durat
exposur
host
genotyp
strain
cryptococcu
util
earli
studi
success
initi
infect
computercontrol
facil
avail
cryptococcu
speci
yet
taxonom
differenti
mate
product
spore
versu
yeast
fulli
appreci
madison
aerosol
chamber
colleg
engin
shop
univers
wisconsin
standard
apparatu
aerosol
exposur
primari
pathogen
design
nation
institut
allergi
infecti
diseas
signific
technolog
advanc
allow
computercontrol
devic
within
madison
chamber
obtain
sampl
preand
postnebul
exposur
chamber
biosampl
adjust
monitor
rel
humid
within
chamber
collect
pertin
data
mass
size
aerosol
cell
expos
mice
data
determin
effect
temperatur
rel
humid
nebul
process
cell
addit
calcul
dose
mice
expos
given
time
period
facilit
establish
defin
aerobiolog
exposur
paramet
given
pathogen
studi
first
contemporari
applic
madison
chamber
establish
well
valid
aerosol
model
murin
infect
cryptococcu
defin
prepar
inoculum
concentr
inoculum
particl
size
distribut
consist
effici
aerosol
defin
aerobiolog
exposur
paramet
effect
consist
deliveri
aerosol
cryptococcu
cell
mice
well
valid
inhal
model
consider
potenti
facilit
novel
insight
primari
exposur
rout
cryptococcu
human
time
cours
diseas
develop
environment
condit
enhanc
risk
acquisit
role
spore
andor
yeast
infect
process
virul
diverg
mate
type
genotyp
could
lead
novel
prevent
strategi
therapeut
modal
experi
perform
c
neoforman
var
neoforman
c
neoforman
var
grubii
c
gattii
tabl
preliminari
aerosol
test
vari
growth
condit
exposur
time
humid
increas
viabl
number
cell
mice
would
expos
within
wholebodi
exposur
apparatu
dose
present
determin
viabl
biosampl
densiti
aim
obtain
calcul
dose
present
greater
cellsmous
maxim
dose
deliv
retent
within
lung
variou
trial
cell
grown
yeast
pepton
dextros
broth
ypd
yeast
extract
pepton
glucos
prepar
directli
liquid
prepar
grown
ypd
subject
natur
evapor
dri
mimic
desicc
natur
resuspend
water
nebul
subcultur
ypd
broth
inocul
agar
growth
mate
product
dri
yeast
spore
although
cell
initi
grown
differ
method
cryptococcu
strain
collect
ml
cellml
suspens
use
standard
inoculum
densiti
aerobiolog
exposur
confirm
densiti
cell
prepar
prior
nebul
prenebul
cfuml
madison
chamber
ml
aliquot
everi
final
prepar
taken
dilut
ypd
agar
triplic
colonyform
unit
cfu
determin
compar
expect
cellml
total
eleven
trial
experi
perform
eight
without
mice
three
util
mice
tabl
brothgrown
cryptococcu
cell
passag
twice
ml
flask
contain
ml
ypd
broth
shake
overnight
hr
cell
collect
centrifug
wash
resuspend
ml
autoclav
millipor
water
cell
densiti
determin
hemacytomet
ml
cellml
suspens
prepar
strain
cell
subject
dri
prior
use
madison
chamber
grown
ident
condit
broth
grown
cell
initi
collect
centrifug
resuspens
ml
water
cell
pour
steril
petri
plate
lid
place
slightli
ajar
allow
air
dri
bslii
hood
overnight
cell
collect
count
hemacytomet
dilut
standard
densiti
trial
cryptococcu
cell
grown
agar
ph
arabidopsi
leaf
agar
g
chop
arabidopsi
thaliana
leavesl
glucos
agar
mimic
plant
substrat
environ
cryptococcu
known
grow
mate
cryptococcu
strain
grown
subcultur
twice
ml
ypd
broth
collect
centrifug
wash
twice
ml
autoclav
millipor
water
resuspend
ml
autoclav
water
ml
strain
spread
individu
onto
agar
arabidopsi
agar
plate
incub
room
temperatur
dark
two
three
week
coloni
scrape
plate
wash
suspend
ml
water
count
hemacytomet
dilut
standard
cell
densiti
induc
mate
collect
yeastspor
mixtur
strain
grown
combin
agar
ph
cell
subcultur
prepar
plate
suspens
ml
water
equal
proport
ml
cell
mix
cell
individu
ml
volum
spot
four
six
agar
plate
plate
incub
dark
room
room
temperatur
three
four
week
prolif
sporul
confirm
light
microscopi
mate
coloni
includ
yeast
spore
scrape
wash
autoclav
water
plate
resuspend
autoclav
water
suspens
centrifug
wash
resuspend
ml
water
count
hemacytomet
dilut
standard
inoculum
cell
densiti
cryptococcu
aerosol
gener
use
collison
nebul
bgi
inc
oper
airflowr
lpm
psi
connect
wholebodi
madison
exposur
chamber
figur
trial
util
humidifi
air
nebul
air
mix
humidifi
air
lpm
enter
madison
chamber
humidifi
air
gener
two
humidifi
connect
seri
lab
commerc
inc
humid
chamber
control
rel
humid
rh
measur
realtim
aerosol
exposur
nebul
humidifi
air
flow
rate
control
aeromp
aerosol
manag
platform
biaera
technolog
llc
madison
chamber
oper
neg
pressur
inch
water
column
use
vacuum
pump
cryptococcu
aerosol
insid
madison
chamber
sampl
use
skc
biosampl
skc
inc
model
aerodynam
particl
sizer
ap
tsi
inc
start
stop
oper
ap
biosampl
control
aeromp
particl
size
distribut
count
mass
measur
ap
twominut
interv
second
durat
aerosol
exposur
aeromp
use
calcul
count
mean
aerodynam
diamet
cmad
mass
mean
aerodynam
diamet
mmad
mmad
use
describ
polydispers
aerosol
particl
size
mass
particl
contain
geometr
standard
deviat
gsd
calcul
use
particl
size
distribut
mass
aliquot
obtain
postnebul
biosampl
dilut
plate
triplic
ypd
agar
incub
room
temperatur
two
four
day
averag
cfusml
calcul
data
util
determin
effect
nebul
viabil
cryptococcu
cell
compar
cfu
prior
nebul
postnebul
postnebul
prenebul
ratio
equal
greater
one
indic
surviv
post
nebul
wherea
ratio
valu
less
one
indic
decreas
viabil
postnebul
viabl
aerosol
densiti
c
use
calcul
spray
factor
f
ratio
viabl
aerosol
concentr
chamber
start
inoculum
densiti
nebul
viabl
aerosol
concentr
c
calcul
c
ac
sam
vb
qb
c
sam
concentr
biosampl
v
bs
volum
liquid
biosampl
aerosol
exposur
aerosol
exposur
time
durat
q
bs
biosampl
air
flow
rate
spray
factor
calcul
f
sc
cs
c
viabl
aerosol
concentr
c
nebul
sampl
concentr
dose
present
dp
calcul
use
guyton
formula
v
bw
weight
mice
gram
v
minut
volum
v
evm
v
e
exposur
volum
exposur
time
pve
c
p
dose
present
c
viabl
aerosol
concentr
total
ml
steril
filter
water
use
biosampl
captur
aerosol
sampl
use
determin
cell
densiti
viabil
aerosol
cryptococcu
insid
madison
chamber
densiti
use
calcul
dose
present
p
mice
use
guyton
formula
graphpad
prism
version
window
graphpad
softwar
san
diego
california
usa
use
data
analysi
construct
graph
pvalu
linear
regress
analysi
calcul
use
ftest
twoway
anova
use
compar
cfu
anim
studi
conduct
divis
laboratori
anim
resourc
dlar
facil
duke
univers
medic
center
dumc
handl
accord
guidelin
defin
unit
state
anim
welfar
act
full
complianc
dumc
institut
anim
care
use
committe
iacuc
aerosol
infect
model
review
approv
dumc
iacuc
iacuc
protocol
six
week
old
ajcr
mice
cat
ncifrederick
mice
cat
jackson
lab
use
mice
acclimat
facil
one
week
prior
aerosol
challeng
hous
hermet
seal
cage
humid
hr
hr
dark
simul
aerosol
gener
natur
aim
increas
dose
present
mice
air
dri
cell
grown
broth
grew
cell
agar
observ
increas
dose
present
extend
aerosol
trial
includ
mice
proof
principl
eight
mice
use
confirm
abl
deliv
retain
viabl
cryptococcu
cell
within
mous
lung
dose
retain
dose
retain
determin
viabl
cfu
lung
homogen
four
mice
expos
aerosol
c
gattii
strain
grown
ypd
broth
airdri
cell
grown
arabidopsi
agar
mice
expos
aerosol
cryptococcu
wholebodi
exposur
chamber
min
standard
aerobiolog
condit
lpm
airflowr
psi
rh
one
hour
postexposur
mice
human
euthan
lung
spleen
brain
tissu
steril
collect
blsii
hood
homogen
ml
phosphat
buffer
salin
pb
ml
directli
stock
dilut
plate
ypd
agar
triplic
incub
two
four
day
cfu
calcul
determin
dose
retain
mous
lung
dose
retain
within
lung
function
aerodynam
particl
size
dose
expos
respiratori
rate
volum
anim
model
extend
valid
protocol
assess
deliveri
aerosol
yeast
spore
eight
ajcr
mice
per
group
expos
aerosol
yeastspor
mixtur
obtain
mate
mixtur
wholebodi
exposur
chamber
one
hour
standard
aerobiolog
condit
lpm
air
flowrat
psi
rh
four
mice
per
group
humanli
euthan
lung
spleen
brain
tissu
steril
collect
one
hour
three
week
post
exposur
cfu
determin
previous
describ
addit
experi
util
previous
construct
c
neoforman
var
grubii
strain
contain
select
marker
nourseothricin
nat
neomycin
neo
resist
determin
could
track
contribut
spore
versu
yeast
throughout
aerosol
process
infect
process
tabl
aim
determin
spore
surviv
nebul
aerosol
retain
within
lung
better
yeast
cell
strain
grown
individu
ypd
broth
drug
select
spot
plate
agar
without
drug
addit
alon
combin
describ
induc
mate
independ
cultur
cell
harvest
plate
dilut
cellml
ml
cell
prepar
mix
togeth
constitut
mix
inoculum
without
spore
prenebul
postnebul
biosampl
mous
tissu
cfu
determin
plate
ypd
agar
ypd
contain
nat
mgml
ypd
contain
neo
mgml
ypd
contain
nat
neo
statist
analys
carri
use
prism
version
linear
regress
use
assess
correl
student
ttest
use
pairwis
comparison
spray
factor
ratio
viabl
aerosol
output
divid
origin
suspens
concentr
throughout
trial
experi
vari
tabl
higher
spray
factor
correl
increas
dispers
exposur
infecti
particl
aerosol
exposur
increas
spray
factor
observ
cell
c
neoforman
var
grubii
c
gattii
grown
arabidopsi
leaf
p
agar
p
comparison
ypd
brothgrown
cell
rel
humid
rh
figur
tabl
significantli
higher
log
spray
factor
brothgrown
cell
observ
rh
comparison
aerosol
rh
figur
growth
agar
increas
humid
increas
viabl
aerosol
concentr
biosampl
dose
present
c
neoforman
var
grubii
c
gattii
insid
madison
chamber
p
rh
p
growth
agar
result
significantli
higher
valu
viabl
aerosol
brothgrown
cell
figur
viabl
biosampl
concentr
preliminari
experi
rh
rang
cellml
brothgrown
cellsml
arabidopsi
agargrown
signific
posit
correl
rh
spray
factor
observ
c
neoforman
var
grubii
figur
p
r
similar
nonsignific
trend
also
observ
c
gattii
figur
p
r
within
singl
trial
c
neoforman
var
neoforman
cell
tabl
trial
data
increas
biosampl
concentr
obtain
increas
humid
increas
durat
exposur
tabl
direct
signific
correl
increas
humid
increas
aerosol
concentr
observ
figur
p
r
nonstatist
trend
observ
c
gattii
figur
p
r
c
neoforman
var
neoforman
tabl
trial
aerosol
concentr
show
greater
stabil
high
humid
greater
variabl
observ
lower
humid
figur
highest
consist
aerosol
concentr
obtain
growth
agar
media
aerosol
humid
one
hour
figur
tabl
mice
expos
aerosol
three
independ
trial
experi
tabl
trial
deliveri
aerosol
cryptococcu
cell
lung
mice
success
three
trial
first
preliminari
mous
exposur
ypddri
arabidopsi
leaf
agar
mice
expos
aerosol
c
gattii
rh
minut
retain
viabl
c
gattii
one
hour
post
exposur
tabl
observ
mice
retain
viabl
c
neoforman
var
grubii
cell
within
lung
mice
expos
one
hour
rh
c
neoforman
var
grubii
mate
mixtur
spore
aerosol
individu
exposur
averag
dose
retain
cellslung
cellslung
cellslung
respect
figur
although
dose
retain
mate
mixtur
spore
higher
yeast
alon
differ
statist
signific
spleen
brain
tissu
colon
cryptococcu
one
hour
postexposur
figur
day
durat
experiment
exposur
mice
display
pattern
weight
loss
signific
increas
tissu
burden
lung
brain
spleen
one
mous
expir
prior
day
timepoint
consist
diseas
develop
figur
addit
use
c
neoforman
var
grubii
strain
drug
resist
marker
nourseothricin
nat
neomycin
neo
tabl
consolid
exposur
mix
equal
portion
use
yeast
control
mate
mixtur
contain
yeast
spore
similarli
observ
lower
dose
retain
mice
expos
yeast
alon
cellsmous
versu
yeast
spore
mixtur
cellsmous
figur
although
dose
retain
mate
mixtur
spore
higher
yeast
alon
differ
statist
signific
abl
track
presenc
nat
neo
natand
neoresist
coloni
aerosol
postnebul
doublydrug
resist
coloni
repres
less
cell
obtain
preand
postnebul
also
notic
larg
dispar
total
cfu
ypd
agar
total
cfu
neoresist
cell
indic
gener
loss
neo
resist
marker
data
shown
week
incub
observ
loss
neo
r
cell
strain
incub
alon
combin
growth
nonmat
neo
mark
parent
strain
retain
neo
resist
contrast
neo
r
cell
isol
mate
coloni
retain
neo
select
marker
observ
loss
neo
resist
strain
confirm
neo
marker
episom
integr
pcr
prevent
extens
experi
explor
role
spore
infect
process
summari
obtain
natand
neoresist
coloni
observ
doubledrug
resist
coloni
biosampl
lung
tissu
mice
aerodynam
particl
size
concentr
stabil
aerosol
exposur
aerodynam
particl
characterist
mass
mean
aerodynam
diamet
mmad
count
mean
aerodynam
diamet
cmad
geometr
standard
deviat
gsd
determin
independ
trial
exposur
involv
c
neoforman
var
neoforman
c
neoforman
var
grubii
c
gattii
figur
mmad
distribut
similar
variabl
among
trial
rang
mm
figur
tabl
howev
mmad
indic
particl
size
consist
respir
rang
less
mm
except
trial
particl
size
rang
mm
mm
observ
mmad
cmad
gsd
c
neoforman
c
gattii
similar
mmad
c
gattii
rang
mm
mm
cmad
gsd
rang
mmad
c
neoforman
var
grubii
rang
mm
mm
cmad
gsd
rang
gener
observ
mmad
consist
humid
particl
size
distribut
count
mass
variabl
rang
mm
higher
concentr
mass
particl
less
mm
observ
figur
particl
densiti
mass
profil
c
gattii
consist
increas
aerosol
time
minut
figur
agar
grown
c
gattii
exhibit
one
major
particl
diamet
peak
around
mm
figur
b
c
contrast
two
peak
mm
mm
observ
broth
grown
cell
figur
agar
grown
cryptococcu
cell
figur
b
c
exhibit
consist
aerodynam
particl
diamet
mass
densiti
profil
versu
ypdbroth
figur
e
ypddri
cell
figur
aerosol
c
neoforman
var
grubii
particl
densiti
mass
size
profil
remain
consist
humid
figur
brothgrown
cell
figur
display
broad
aerodynam
particl
rang
contrast
c
gattii
broth
grown
figur
agar
grown
cell
figur
particl
mass
size
densiti
distribut
similar
yeast
cell
mate
mixtur
contain
yeast
spore
figur
size
aerosol
c
neoforman
var
grubii
particl
stabl
minut
exposur
humid
figur
coeffici
varianc
mmad
rh
rh
rh
concentr
particl
gener
consist
rh
rh
figur
coeffici
varianc
relat
cell
densiti
higher
rh
rh
rh
first
publish
report
demonstr
use
madison
chamber
coupl
sampl
port
softwar
aerosol
deliveri
cryptococcu
mice
demonstr
abil
aerosol
viabl
c
neoforman
c
gattii
cell
respir
rang
produc
adequ
deliveri
initi
diseas
murin
host
multiplex
sampl
port
coupl
softwar
interfac
allow
measur
viabl
aerosol
concentr
spray
factor
dose
present
particl
size
characterist
data
essenti
defin
aerobiolog
paramet
optim
consist
deliveri
cryptococcu
murin
lung
understand
characterist
aerosol
cryptococcu
gener
deliveri
retent
preliminari
trial
perform
confirm
viabil
cryptococcu
cell
postnebul
quantiti
viabl
cell
respir
rang
mm
deposit
lung
initi
inoculum
densiti
maxim
cellsml
ml
volum
viabil
cryptococcu
postnebul
previous
determin
yeast
cell
larger
mm
typic
aerosol
pathogen
inoculum
densiti
similar
previou
report
use
initi
c
neoforman
aspergillu
bacteri
aerosol
infect
experi
util
greater
volum
previous
report
densiti
viabl
cryptococcu
yeast
cell
postnebul
equal
greater
inoculum
densiti
prenebul
high
viabil
postnebul
correl
high
spray
factor
observ
higher
spray
factor
cryptococcu
previous
report
primari
bacteri
pathogen
yersinia
pesti
bacillu
anthraci
mycobacterium
tuberculosi
cryptococcu
environment
organ
isol
plant
soil
guano
cryptococcu
may
surviv
nebul
better
organ
environ
surviv
harsh
condit
long
period
time
withstand
desicc
natur
irradi
passag
host
temperatur
fluctuat
possibl
due
polysaccharid
capsul
abil
melan
small
increas
cell
densiti
observ
postnebul
like
artifact
loss
water
volum
nebul
process
result
increas
viabil
replic
except
one
trial
mmad
less
mm
within
respir
rang
outlier
trial
mmad
rang
mm
mm
suspect
unusu
mmad
observ
may
result
ineffici
desicc
yeast
cell
prior
resuspens
nonstandard
growth
condit
unexplain
measur
malfunct
aerosol
initi
two
trial
util
broth
grown
cell
result
low
inconsist
dose
present
cellsmous
sukroongreung
et
al
estim
spore
load
inhal
mous
minut
exposur
cell
exceed
observ
effect
aerosol
deliveri
bacteria
murin
lung
report
dose
present
rang
cellsmous
aerosol
deliveri
aspergillu
fumigatu
conidia
result
dose
retain
cellsmous
aim
obtain
calcul
dose
present
greater
cellsmous
maxim
dose
deliv
retent
within
mous
lung
cryptococcu
yeast
cell
larger
aspergillu
conidia
bacteri
cell
deliv
aerosol
challeng
mm
mm
versu
mm
mm
respect
principl
confirm
sinc
observ
rang
mmad
cmad
gsd
aerosol
cryptococcu
cell
larger
variabl
previous
report
variou
bacteria
fungi
observ
broaden
aerodynam
size
rang
c
gattii
compris
two
distinct
peak
concentr
comparison
c
neoforman
display
smaller
size
rang
one
singl
broad
peak
size
rang
observ
appear
consist
previou
morpholog
descript
detail
larger
elong
yeast
spore
morpholog
c
gattii
contrast
consist
round
cell
morpholog
c
neoforman
attempt
maxim
dose
present
grew
cryptococcu
cell
differ
laboratori
condit
would
close
mimic
condit
natur
result
substrategrown
andor
desicc
cell
cell
grown
ypd
broth
subject
natur
desicc
overnight
grown
arabidopsi
agar
third
trial
abl
monitor
rel
humid
addit
integr
packag
previous
unavail
observ
increas
viabl
biosampl
concentr
result
calcul
dose
present
attain
predict
cut
valu
cellsmous
ypddri
arabidopsi
agargrown
cell
increas
calcul
dose
present
could
attribut
rel
humid
andor
chang
cell
prepar
methodolog
addit
experiment
necessari
establish
import
factor
rel
humid
cell
growth
condit
known
impact
surviv
infect
bacteria
virus
addit
trial
exposur
without
mice
conduct
expand
aerosol
model
c
neoforman
attempt
determin
whether
humid
import
factor
success
cryptococcu
aerosol
model
observ
linear
increas
trend
c
neoforman
var
grubii
biosampl
cell
densiti
dose
present
posit
correl
increas
humid
experi
combin
addit
experi
confirm
increas
humid
aerosoli
increas
viabl
aerosol
dose
present
c
neoforman
var
neoforman
c
neoforman
var
grubii
c
gattii
follow
find
aerosol
experi
conduct
optim
humid
rh
humid
implic
key
factor
viabil
transmiss
influenza
viru
francisella
tularensi
bacteria
low
humid
associ
increas
transmiss
high
humid
associ
lower
transmiss
influenza
increas
environment
isol
cryptococcu
gattii
associ
flower
eucalyptu
australia
dri
hot
summer
vancouv
bc
pacif
northwestern
usa
find
humid
influenc
viabil
transmiss
infecti
propagul
fungal
viral
bacteri
pathogen
suggest
factor
may
contribut
season
pattern
diseas
incid
follow
preliminari
experi
immedi
move
conduct
wholebodi
aerosol
exposur
mice
trial
upon
observ
dose
present
cellsmous
order
test
development
criteria
cryptococcu
aerosol
exposur
model
mice
expos
c
gattii
cell
ypddri
arabidopsi
agar
prepar
dose
present
arabidopsi
agar
prepar
slightli
higher
observ
mice
expos
brothgrown
dri
cell
abil
precis
determin
viabl
aerosol
present
biosampl
dose
present
dose
retain
experi
util
madison
chamber
set
studi
apart
previous
publish
report
aerosol
cryptococcu
soil
seed
fourday
exposur
limit
determin
dose
expos
dose
retain
mice
expos
cryptococcu
via
soil
exposur
methodolog
exposur
via
jet
nebul
henderson
chamber
much
similar
exposur
via
madison
chamber
henc
readili
compar
smith
et
al
report
mice
receiv
viabl
cell
valu
far
exce
cfu
obtain
post
mous
expir
methodolog
specif
valu
calcul
like
smith
et
al
describ
viabl
cell
receiv
compar
either
biosampl
densiti
viabl
dose
present
mice
former
like
biosampl
densiti
cellsml
cellsml
similar
observ
viabl
cell
receiv
report
studi
mice
expos
ypddri
prepar
quantifi
dose
retain
lung
versu
mice
expos
arabidopsi
agar
prepar
rate
initi
colon
similar
termin
infect
report
smith
et
al
much
higher
mortal
rate
obtain
sukroongreung
et
al
contrast
aerosol
deliveri
aspergillu
immunocompromis
mice
result
much
higher
lung
burden
dose
retain
result
mortal
cfu
observ
lung
variabl
cell
mous
fraction
dose
present
retain
lung
cell
may
lodg
upper
respiratori
system
nose
mouth
throat
may
immedi
contribut
dose
retain
cell
deposit
upper
lower
respiratori
tract
could
clear
exhal
kill
host
defens
mechan
contribut
later
develop
infect
actual
dose
present
dose
retain
mous
address
fu
et
al
averag
cfu
lung
blood
brain
tissu
determin
three
seven
day
postexposur
dose
retain
onehour
postexposur
experi
much
lower
cfu
obtain
report
three
day
seven
day
postexpir
previou
report
timepoint
chosen
assay
dose
retain
vari
immedi
postexposur
hr
depend
organ
aim
obtain
viabl
number
cryptococcu
cell
reach
lung
minim
potenti
effect
kill
host
immunolog
system
replic
dissemin
cryptococcu
defin
dose
retain
onehour
timepoint
previou
studi
indic
macrophag
quickli
initi
kill
within
two
hour
signific
differ
kill
cryptococcu
observ
within
one
four
hour
vitro
incub
macrophag
neutrophil
furthermor
previou
report
establish
develop
dissemin
cryptococcu
often
occur
within
hour
intranas
exposur
macrophag
implic
exit
cryptococcu
lung
dissemin
blood
passag
blood
brain
barrier
colon
brain
expect
initi
dose
retain
increas
time
cryptococcu
abl
surviv
replic
within
host
addit
anim
exposur
perform
mate
nonmat
c
neoforman
var
grubii
order
determin
low
dose
retain
suffici
initi
diseas
develop
whether
presenc
spore
enhanc
cryptococcu
viabil
aerosoli
increas
dose
retain
enhanc
develop
diseas
yeast
aerosol
separ
mate
mixtur
contain
hyphal
fragment
yeast
spore
signific
differ
observ
prenebul
postnebul
biosampl
spray
factor
dose
present
yeast
cell
alon
combin
spore
observ
higher
nonsignific
dose
retain
mice
expos
mate
mixtur
yeastspor
time
possibl
small
differ
could
import
diseas
progress
develop
system
cryptococcosi
expect
spleen
brain
tissu
colon
cryptococcu
one
hour
post
exposur
durat
experi
mice
display
pattern
weight
loss
signific
increas
tissu
burden
lung
brain
spleen
one
mous
expir
prior
timepoint
consist
diseas
develop
observ
increas
cfu
dissemin
brain
weight
loss
death
indic
progress
diseas
develop
consist
murin
infect
model
observ
signific
differ
viabl
densiti
postnebul
particl
size
mass
densiti
distribut
yeast
cell
mate
mixtur
contain
spore
data
suggest
yeast
cell
spore
similar
abil
surviv
nebul
share
overlap
particl
size
mass
densiti
characterist
aerosol
increas
rel
humid
may
contribut
increas
viabil
desicc
yeast
cell
postnebul
data
support
idea
natur
yeast
cell
spore
serv
infecti
particl
risk
cryptococcu
infect
may
differ
season
vari
environment
factor
humid
addit
research
need
determin
differ
exist
abil
spore
versu
yeast
cell
travers
lower
respiratori
tract
enter
surviv
replic
exit
macrophag
contribut
enhanc
infect
dissemin
demonstr
rel
humid
obtain
infect
mice
exce
infect
effici
report
aerosol
deliveri
via
crude
soil
seed
jet
nebul
henderson
apparatu
develop
wellvalid
aerosol
model
cryptococcu
util
madison
chamber
coupl
instrument
data
suggest
novel
role
rel
humid
viabil
infect
cryptococcu
defin
inoculum
growth
cell
densiti
aerobiolog
deliveri
paramet
consist
deliveri
low
number
cryptococcosi
murin
lung
attach
class
iii
biosafeti
cabinet
aeromp
collect
data
chamber
pressur
sensor
rel
humid
temperatur
probe
aerodynam
particl
sizer
ap
aeromp
also
control
nebul
flow
dilut
airflow
humidifi
biosampl
ap
mice
expos
whole
bodi
exposur
apparatu
particl
mass
open
blue
triangl
particl
densiti
open
red
circl
plot
respect
particl
diamet
tif
figur
aerodynam
particl
characterist
c
gattii
aerosol
agar
grown
cell
display
consist
particl
size
mass
densiti
comparison
cell
grown
ypdbroth
aerodynam
properti
cell
grown
broth
dri
consist
cell
prepar
aerosol
without
dri
arabidopsi
agar
trial
b
arabidopsi
agar
trial
c
arabidopsi
agar
trial
ypddri
trial
e
ypddri
trial
f
ypdbroth
rh
particl
mass
open
blue
triangl
particl
densiti
open
red
circl
plot
respect
particl
diamet
tif
figur
aerodynam
particl
characterist
c
neoforman
var
grubii
remain
stabl
aerosol
differ
rel
humid
trial
ypdbroth
grown
rh
b
rh
c
rh
particl
mass
open
blue
triangl
particl
densiti
open
red
circl
plot
respect
particl
diamet
tif
particl
mass
open
blue
triangl
particl
densiti
open
red
circl
plot
respect
particl
diamet
cell
agar
grown
aerosol
rel
humid
tif
figur
cryptococcu
particl
size
stabil
densiti
aerosol
exposur
aerodynam
mass
distribut
measur
use
aerodynam
particl
sizer
ap
connect
madison
chamber
sampl
done
second
everi
minut
minut
trial
aerosol
mmad
aerosol
concentr
b
c
neoforman
var
grubii
measur
mmad
remain
consist
aerosol
differ
rel
humid
particl
densiti
chang
min
exposur
aerosol
humid
remain
constant
aerosol
rel
humid
circl
rh
squar
rh
triangl
rh
tif
